Moderna executives have cashed out $89M in shares this year, as stock price has soared on vaccine hopes
With the firm in the spotlight for its Covid-19 vaccine, five executives have initiated nearly three times as many stock transactions than in all of 2019.
No hay comentarios:
Publicar un comentario